References
- Peterson LS, Nelson AM, Su WP, et al. The epidemiology of morphea (localized scleroderma) in Olmsted County 1960–1993. J Rheumatol 1997;24:73–80.
- Zulian F, Athreya BH, Laxer R, et al. Juvenile localized scleroderma: clinical and epidemiological features in 750 children. An International study. Rheumatology (Oxford) 2006;45:614–20.
- Mertens JS, Seyger MMB, Kievit W, et al. Disease recurrence in localized scleroderma: a retrospective analysis of 344 patients with paediatric- or adult-onset disease. Br J Dermatol 2015;172:722–28.
- Kreuter A, Wischnewski J, Terras S, et al. Coexistence of lichen sclerosus and morphea: a retrospective analysis of 472 patients with localized scleroderma from a German tertiary referral center. J Am Acad Dermatol 2012;67:1157–62.
- Marzano AV, Menni S, Parodi A, et al. Localized scleroderma in adults and children. Clinical and laboratory investigations on 239 cases. Eur J Dermatol 2003;13:171–76.
- Kister I, Inglese M, Laxer RM, Herbert J. Neurological manifestations of localized scleroderma: a case report and literature review. Neurology 2008;71:1538–45.
- Amaral TN, Peres FA, Lapa AT, et al. Neurological involvement in scleroderma: a systematic review. Semin Arthritis Rheum 2013;43:335–47.
- Careta MF, Leite Cda C, Cresta F, et al. Prospective study to evaluate the clinical and radiological outcome of patients with scleroderma of the face. Autoimmun Rev 2013;12:1064–69.
- Zannin ME, Martini G, Athreya BH, et al. Juvenile scleroderma working group of the pediatric rheumatology European society (PRES). Ocular involvement in children with localised scleroderma: a multi-centre study. Br J Ophthalmol 2007;91:1311–14.
- Bucher F, Fricke J, Neugebauer A, et al. Ophthalmological manifestations of Parry–Romberg syndrome. Surv Ophthalmol 2016. pii: S0039-6257(15)30073-4. doi:10.1016/j.survophthal.2016.03.009. [Epub ahead of print]
- Tollefson MM, Witman PM. En coup de sabre morphea and Parry–Romberg syndrome: a retrospective review of 54 patients. J Am Acad Dermatol 2007;56:257–63.
- Chini L, Orlacchio A, Silenzi R, et al. Neuroimaging is useful for monitoring disease activity in linear scleroderma "en coup de sabre. Minerva Pediatr 2014;66:89–93.
- Laxer RM, Zulian F. Localized scleroderma. Curr Opin Rheumatol 2006;18:606–13.
- Blaszczyk M, Królicki L, Krasu M, et al. Progressive facial hemiatrophy: central nervous system involvement and relationship with scleroderma en coup de sabre. J Rheumatol 2003;30:1997–2004.
- Holland KE, Steffes B, Nocton JJ, et al. Linear scleroderma en coup de sabre with associated neurological abnormalities. Pediatrics 2006;117:e132–36.
- Korkmaz C, Adapinar B, Uysal S. Beneficial effect of immunosuppressive drugs on Parry–Romberg syndrome: a case report and review of the literature. South Med J 2005;98:940–42.
- Doolittle DA, Lehman VT, Schwartz KM, et al. CNS imaging findings associated with Parry-Romberg syndrome and en coup de sabre: correlation to dermatologic and neurologic abnormalities. Neuroradiology 2015;57:21–34.
- Littman BH. Linear scleroderma: a response to neurologic injury? Report and literature review. J Rheumatol 1989;16:1135–40.
- Miyamoto M, Kinoshita M, Tanaka K, Tanaka M. Recurrent myelitis in localized scleroderma. Clin Neurol Neurosurg 2014;127:140–42.